دورية أكاديمية
NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity
العنوان: | NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity |
---|---|
المؤلفون: | Wojnowski, L., Kulle, B., Schirmer, M., Schlüter, G., Schmidt, A., Rosenberger, A., Vonhof, S., Bickeböller, H., Toliat, M., Suk, E., Tzvetkov, M., Kruger, A., Seifert, S., Kloess, M., Hahn, H., Loeffler, M., Nürnberg, P., Pfreundschuh, M., Trümper, L., Brockmöller, J., Hasenfuss, G. |
المصدر: | Circulation |
سنة النشر: | 2005 |
المجموعة: | Max Planck Society: MPG.PuRe |
الوصف: | Background: A significant number of patients treated with anthracyclines develop cardiotoxicity (anthracycline-induced cardiotoxicity [ACT]), mainly presenting as arrhythmias (acute ACT) or congestive heart failure (chronic ACT). There are no data on pharmacogenomic predictors of ACT. Methods and Results: We genotyped participants of the German non-Hodgkin lymphoma study (NHL-B) who were followed up for the development of heart failure for a median of >3 years. Single-nucleotide polymorphisms (SNPs) were selected from 82 genes with conceivable relevance to ACT. Of 1697 patients, 55 developed acute and 54 developed chronic ACT (cumulative incidence of either form, 3.2%). We detected 5 significant associations with polymorphisms of the NAD(P)H oxidase and doxorubicin efflux transporters. Chronic ACT was associated with a variant of the NAD(P)H oxidase subunit NCF4 (rs1883112, -212A->G; symbols with right-pointing arrows, as edited?‘ odds ratio [OR], 2.5; 95% CI, 1.3 to 5.0). Acute ACT was associated with the His72Tyr polymorphism in the p22phox subunit (rs4673; OR, 2.0; 95% CI, 1.0 to 3.9) and with the variant 7508T->A (rs13058338; OR, 2.6; 95% CI, 1.3 to 5.1) of the RAC2 subunit of the same enzyme. In agreement with these results, mice deficient in NAD(P)H oxidase activity, unlike wild-type mice, were resistant to chronic doxorubicin treatment. In addition, acute ACT was associated with the Gly671Val variant of the doxorubicin efflux transporter multidrug resistance protein 1 (MRP1) (OR, 3.6; 95% CI, 1.6 to 8.4) and with the Val1188Glu-Cys1515Tyr (rs8187694-rs8187710) haplotype of the functionally similar MRP2 (OR, 2.3; 95% CI, 1.0 to 5.4). Polymorphisms in adrenergic receptors previously demonstrated to be predictive of heart failure were not associated with ACT. Conclusions: Genetic variants in doxorubicin transport and free radical metabolism may modulate the individual risk to develop ACT. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
العلاقة: | http://hdl.handle.net/11858/00-001M-0000-0010-8558-1Test |
الإتاحة: | http://hdl.handle.net/11858/00-001M-0000-0010-8558-1Test |
رقم الانضمام: | edsbas.902D5922 |
قاعدة البيانات: | BASE |
ResultId |
1 |
---|---|
Header |
edsbas BASE edsbas.902D5922 765 3 Academic Journal academicJournal 764.67431640625 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.902D5922&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => http://hdl.handle.net/11858/00-001M-0000-0010-8558-1# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Wojnowski%2C+L%2E%22">Wojnowski, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Kulle%2C+B%2E%22">Kulle, B.</searchLink><br /><searchLink fieldCode="AR" term="%22Schirmer%2C+M%2E%22">Schirmer, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Schlüter%2C+G%2E%22">Schlüter, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Schmidt%2C+A%2E%22">Schmidt, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Rosenberger%2C+A%2E%22">Rosenberger, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Vonhof%2C+S%2E%22">Vonhof, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Bickeböller%2C+H%2E%22">Bickeböller, H.</searchLink><br /><searchLink fieldCode="AR" term="%22Toliat%2C+M%2E%22">Toliat, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Suk%2C+E%2E%22">Suk, E.</searchLink><br /><searchLink fieldCode="AR" term="%22Tzvetkov%2C+M%2E%22">Tzvetkov, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Kruger%2C+A%2E%22">Kruger, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Seifert%2C+S%2E%22">Seifert, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Kloess%2C+M%2E%22">Kloess, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Hahn%2C+H%2E%22">Hahn, H.</searchLink><br /><searchLink fieldCode="AR" term="%22Loeffler%2C+M%2E%22">Loeffler, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Nürnberg%2C+P%2E%22">Nürnberg, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Pfreundschuh%2C+M%2E%22">Pfreundschuh, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Trümper%2C+L%2E%22">Trümper, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Brockmöller%2C+J%2E%22">Brockmöller, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Hasenfuss%2C+G%2E%22">Hasenfuss, G.</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Circulation ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2005 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Max Planck Society: MPG.PuRe ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Background: A significant number of patients treated with anthracyclines develop cardiotoxicity (anthracycline-induced cardiotoxicity [ACT]), mainly presenting as arrhythmias (acute ACT) or congestive heart failure (chronic ACT). There are no data on pharmacogenomic predictors of ACT. Methods and Results: We genotyped participants of the German non-Hodgkin lymphoma study (NHL-B) who were followed up for the development of heart failure for a median of >3 years. Single-nucleotide polymorphisms (SNPs) were selected from 82 genes with conceivable relevance to ACT. Of 1697 patients, 55 developed acute and 54 developed chronic ACT (cumulative incidence of either form, 3.2%). We detected 5 significant associations with polymorphisms of the NAD(P)H oxidase and doxorubicin efflux transporters. Chronic ACT was associated with a variant of the NAD(P)H oxidase subunit NCF4 (rs1883112, -212A->G; symbols with right-pointing arrows, as edited?‘ odds ratio [OR], 2.5; 95% CI, 1.3 to 5.0). Acute ACT was associated with the His72Tyr polymorphism in the p22phox subunit (rs4673; OR, 2.0; 95% CI, 1.0 to 3.9) and with the variant 7508T->A (rs13058338; OR, 2.6; 95% CI, 1.3 to 5.1) of the RAC2 subunit of the same enzyme. In agreement with these results, mice deficient in NAD(P)H oxidase activity, unlike wild-type mice, were resistant to chronic doxorubicin treatment. In addition, acute ACT was associated with the Gly671Val variant of the doxorubicin efflux transporter multidrug resistance protein 1 (MRP1) (OR, 3.6; 95% CI, 1.6 to 8.4) and with the Val1188Glu-Cys1515Tyr (rs8187694-rs8187710) haplotype of the functionally similar MRP2 (OR, 2.3; 95% CI, 1.0 to 5.4). Polymorphisms in adrenergic receptors previously demonstrated to be predictive of heart failure were not associated with ACT. Conclusions: Genetic variants in doxorubicin transport and free radical metabolism may modulate the individual risk to develop ACT. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => http://hdl.handle.net/11858/00-001M-0000-0010-8558-1 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => http://hdl.handle.net/11858/00-001M-0000-0010-8558-1 ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.902D5922 ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Wojnowski, L.
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kulle, B.
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Schirmer, M.
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Schlüter, G.
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Schmidt, A.
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Rosenberger, A.
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Vonhof, S.
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Bickeböller, H.
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Toliat, M.
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Suk, E.
)
)
)
[10] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Tzvetkov, M.
)
)
)
[11] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kruger, A.
)
)
)
[12] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Seifert, S.
)
)
)
[13] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kloess, M.
)
)
)
[14] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Hahn, H.
)
)
)
[15] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Loeffler, M.
)
)
)
[16] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Nürnberg, P.
)
)
)
[17] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Pfreundschuh, M.
)
)
)
[18] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Trümper, L.
)
)
)
[19] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Brockmöller, J.
)
)
)
[20] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Hasenfuss, G.
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2005
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Circulation
[Type] => main
)
)
)
)
)
)
)
|
IllustrationInfo |